20 likes | 159 Views
EUTOS for CML is a unique collaboration between the ELN and Novartis Oncology in Europe to improve understanding of CML, promote best practice and enhance treatment outcomes through four key projects: CML registry Molecular monitoring Path to cure Spread of excellence.
E N D
EUTOS for CML is a unique collaboration between the ELN and Novartis Oncology in Europe • to improve understanding of CML, • promote best practice and • enhance treatment outcomes through four key projects: • CML registryMolecular monitoringPath to cureSpread of excellence For further information and details please visit our website www.eutos.org
CML Registry Baseline-, treatment- and outcome data across Europe Molecular Monitoring Standardized RQ-PCR technologies and establishment of an international definition of complete molecular response Path to Cure Focused on novel treatment findings to further improve CML outcome with the ultimate aim of curing the disease Spread of Excellence Medical education and resources that support physicians in caring for patients with CML www.eutos.org